Dexter Susan (CIK 0001806764)

Latest company ownership

Role: Chief Technical Officer
Shares held
9,643
Last filed at
Dec 3, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 14, 2023 Jun 15, 2023 Sonnet BioTherapeutics Holdings, Inc. Chief Technical Officer Buy 90.0 +10,000 42.25% $7K
May 25, 2021 May 28, 2021 Sonnet BioTherapeutics Holdings, Inc. Chief Technical Officer Sell 26.3 -10,145 -13.78% $15.3K